Choose your sales office
PRODUCT
ELI.H.A Amoeba
Indirect hemagglutination test for serodiagnosis of amoebiasis.
ELI.H.A Amoeba enables the quantitative determination, by indirect hemagglutination, of serum antibodies present in patients suffering from amoebiasis (Entamoeba histolytica).
- Cost-effective test
- Easy and ready-to-use
- High sensitivity and specificity
- Fast results for clinicians (2 hours)
- Simple visual reading, without expert interpretation
| Reference | Name | Quantity |
| 66602 | ELI.H.A Amoeba | 120 tests |
Image Gallery
Benefits
Intended Use
Amoebiasis is a parasitic infection caused by a protozoon specific to humans: Entamoeba histolytica. It’s the only pathogenic amoeba for humans. Immunological diagnosis, via the detection of antibodies, is highly important to confirm hepatic and pulmonary amoeba infections. ELITech developed the ELI.H.A Amoeba, an indirect hemagglutination assay, for the quantitative determination of anti-Entamoeba histolytica antibodies in the serum. It is rapid, easy-to-use and easy-to-read with results available within 2 hours and reliable overnight.
Principle
Sheep red blood cells are sensitized with Entamoeba histolytica antigen. Diluted serum is mixed with sensitized sheep red blood cells. If anti-Entamoeba histolytica antibodies are present in the serum, sensitized red blood cells will agglutinate, resulting in a cloudy red/brown deposit coating the well. In the absence of specific antibodies, sensitized red blood cells will not agglutinate, resulting in a ring-like deposit at the bottom of the well. Non-sensitized red blood cells are also available in the kit. They ensure the specificity of the reaction by allowing identifying any interference from the natural anti-sheep agglutinins (Forssman heteroantibodies, infectious mononucleosis antibodies…). The reaction is carried out in a U-microplate. Each kit allows 120 tests to be carried out or 20 reactions of 6 dilutions. Results are obtained within 2 hours and are reliable overnight.
Simple Protocol
A single protocol for all our ELI.H.A kits.
- First serum dilution
- Micrplate preparation
- Serial dilution of serum and preparation of the ‘serum control’ well
- Addition of sensitized RBC and non sensitized RBC
- Gently mix the plate and let stand 2 hours before readingo
![eliha_methodology[1]](http://www.elitechgroup.com/wp-content/uploads/2015/01/eliha_methodology11.jpg)
The following procedures are therefore valid for all our ELI.H.A range:
Easy-to-read and easy-to-interpret results
![eliha_results[1]](http://www.elitechgroup.com/wp-content/uploads/2015/01/eliha_results11.jpg)
| Titer | Interpretation |
| <1:80 | NEGATIVE REACTION Probable absence of amoeba tissue infection. |
| 1:80≤T≤1:160 | Doubtful reaction A control must be carried out with the electrosyneresis technique, latex agglutination technique (ELITex Bicolor Amoeba) and indirect immunofluorescence. |
| ≥1:320 | SIGNIFICANT REACTION IN FAVOR OF VISCERAL AMOEBIASIS |
Reagents and Material
| Quantity | Description |
| 1 | R1: Vial of 2.4 mL of sensitized red blood cells |
| 1 | R2: Vial of 1 mL of non-sensitized red blood cells |
| 1 | BUF: Vial of 55 mL of phosphate buffer pH 7.2 |
| 1 | R3: Vial of 2 mL of adsorbent |
| 1 | CONTROL +: Vial of 0.2 mL of titrated positive control |
| 1 | CONTROL -: Vial of 0.2 mL of negative control |
| 2 | MICROPLATE: Microplate with a U-bottom |
| 2 | DROPPER: Special dropper |
Stability and Storage
- The reagents are ready-to-use.
- All the reagents are stored at 2-8°C. Do not freeze.
- The results of the stability study indicate that the product has a stability of 24 months from its manufacture.
Material required but not provided
- Automatic pipette(s) with a pipetting volume adapted to the volume that will be measured
- Contaminated waste containers
- Centrifuge
- Hemolysis tubes
Performance
| Sensitivity | Specificity |
| 93% | 97% |
Manufacturer: ELITech Microbio.
Product(s) intended for healthcare professionals.
Read the instructions on the label and/or instructions for use of the product(s).
Let us help you
For general inquiries, please use the links to the right. Click Contact to complete a brief online form, or click Support for general phone and email information. Someone will be in touch with you soon.